Gilead: 2Q Earnings Snapshot

FOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Thursday reported a second-quarter loss of $3.34 billion, after reporting a profit in the same period a year earlier.

On a per-share basis, the Foster City, California-based company said it had a loss of $2.66. Earnings, adjusted for one-time gains and costs, were $1.11 per share.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share.

The HIV and hepatitis C drugmaker posted revenue of $5.14 billion in the period, which also missed Street forecasts. Eight analysts surveyed by Zacks expected $5.24 billion.

Gilead shares have increased 11% since the beginning of the year, while the Standard & Poor's 500 index has stayed nearly flat. In the final minutes of trading on Thursday, shares hit $72.21, a climb of nearly 8% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD